NDC 68788-4085-06 - Amlodipine Besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-4085
- Requested NDC
- 68788-4085-06
- Package NDCs from labels
- 68788-4085-3, 68788-4085-6, 68788-4085-9, 68788-4085-1, 68788-4085-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-02-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amlodipine Besylate - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-02-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-4085-1 | Amlodipine Besylate | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 68788-4085-3 | Amlodipine Besylate | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 68788-4085-6 | Amlodipine Besylate | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 68788-4085-9 | Amlodipine Besylate | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-4085-1 | EA - Each | 68788-4085 | 2eb6c772-632b-4f94-af23-ac1f5a67815d | 1 | 2026-04-20 |
| 68788-4085-3 | EA - Each | 68788-4085 | 40715174-4f94-43ed-96e6-c4907972b7b7 | 1 | 2026-04-20 |
| 68788-4085-6 | EA - Each | 68788-4085 | 9573fc87-d0fc-4b56-aedb-0f9689fe5369 | 1 | 2026-04-20 |
| 68788-4085-9 | EA - Each | 68788-4085 | 687d6966-943d-48f1-869f-451dc362e0e8 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ac0dd8fb-ebe1-4d02-bd0d-4f979c6e3608 | 2026-11-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 47114f60-4151-43d4-ac2d-adc49492a679 | 2026-11-05 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 02e233c4-48d1-456d-8fc8-f99a06ef854a | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | AvKARE | 5f05921c-4f19-3470-e063-6394a90aedd6 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7b5eb6bd-e953-429e-9280-07da4f7d7f47 | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 3bd019d3-b58c-44ab-9190-606a0af5e9b6 | 2026-10-27 | Warnings, Adverse reactions | ANDA078043 308135 864V2Q084H |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Inc. | 14f9b590-4c43-439c-a647-9fc2b0fd4d7f | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 57ffeef7-bfa8-4f92-aadc-23cd00022607 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Redpharm Drug | 58d2fbed-3904-3e31-e063-6294a90af21d | 2026-10-15 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Golden State Medical Supply, Inc. | 47acdbff-b538-9edc-e063-6394a90a3e3b | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 204f27e9-5041-4677-b313-866ca69abad9 | 2026-10-09 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | ScieGen Pharmaceuticals, Inc | c531fceb-09aa-492b-a5a3-2b004e9eadda | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 27b0c628-820a-48bf-a411-86c0ebd4cc8d | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | b4cc6d7e-923b-e81c-e053-2995a90a0731 | 2026-10-05 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | American Health Packaging | 79f41cd2-6d58-4b03-8b0c-ca91398bc1a9 | 2026-10-01 | Warnings, Adverse reactions | 197361 308135 864V2Q084H |
| Caduet | AMLODIPINE AND ATORVASTATIN | Viatris Specialty LLC | 164394b3-d7ba-4bbf-b64b-e2dd15735ea8 | 2026-09-30 | Warnings, Adverse reactions | 864V2Q084H |
| Sdamlo | AMLODIPINE | Pangea Pharmaceuticals, LLC | 886a7f97-60a4-4206-a6c7-5206069ed487 | 2026-09-28 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.